Tandem Diabetes Care, Inc. (TNDM)

Import this data to Google Sheets with:

=jivedata("TNDM","financials")

Full statements spill as a table. For one cell: =jivedata("TNDM","Revenue") or =jivedata("TNDM","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Tandem Diabetes Care, Inc.

TNDM • CIK 0001438133

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$747,718	$940,203	$1,014,736	$1,041,417
Cost of Goods and Services Sold	$380,028	$450,629	$468,722	$458,097
Gross Profit	$367,690	$489,574	$546,014	$583,320
Operating Income (Loss)	$-233,230	$-99,127	$-187,257	$-45,795
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-220,254	$-91,870	$-200,272	$-60,996
Income Tax Expense (Benefit)	$2,357	$4,155	$4,438	$2,319
Net Income (Loss) Attributable to Parent	$-222,611	$-96,025	$-204,710	$-63,315
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-219,425	$-99,341	$-197,170	$-60,657
Weighted Average Number of Shares Outstanding, Basic	64,969,000	65,451,000	67,285,000	69,262,000
Selling, General and Administrative Expense	$352,503	$389,824	$444,989	$441,369
Research and Development Expense (Excluding Acquired in Process Cost)	$169,667	$198,877	$193,114	$187,746
Research and Development Asset Acquired Other than Through Business Combination, Written-off	$78,750	$0	$75,217	$0
Litigation Settlement, Expense	—	—	$19,951	$0
Operating Expenses	$600,920	$588,701	$733,271	$629,115
InterestExpenseNonoperating	—	$7,415	$7,907	$8,794
Income (Loss) from Equity Method Investments	—	$-2,053	$-14,194	$-16,783
Gain (Loss) on Extinguishment of Debt	—	$-1,268	$0	$0
Other Nonoperating Income (Expense)	$12,976	$7,257	$-13,015	$-15,201
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax	—	—	$517	$-1,527
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent	—	—	$-312	$2,718
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent	$-420	$-3,005	$7,335	$1,467

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$58,868	$69,234	$90,634	$62,818
Short-term Investments	$409,044	$369,095	$202,032	$393,178
Property, Plant and Equipment, Net	$76,542	$78,150	$83,580	$84,501
Accounts Receivable, after Allowance for Credit Loss, Current	$105,555	$114,585	$165,491	$162,065
Operating Lease, Right-of-Use Asset	$87,791	$85,306	$96,172	$100,185
Inventory, Net	$157,937	$149,612	$128,769	$135,106
Equity Method Investments	—	$74,545	$60,351	$132,271
Prepaid Expense and Other Assets, Current	$16,585	$21,965	$31,217	$51,472
Other Assets, Noncurrent	$40,336	$5,166	$22,866	$32,606
Assets, Current	$747,989	$724,491	$618,143	$804,639
Assets	$952,658	$967,658	$881,112	$1,154,202
Convertible Debt, Noncurrent	$285,035	$308,266	$310,036	$602,577
Operating Lease, Liability, Noncurrent	$113,572	$106,421	$114,967	$116,411
Contract with Customer, Liability, Noncurrent	$13,331	$10,455	$8,474	$7,776
Other Liabilities, Noncurrent	$31,830	$32,369	$49,741	$44,045
Liabilities	$639,026	$704,560	$725,942	$1,023,814
Commitments and Contingencies	$0	$0	$0	$0
Accounts Payable, Current	$49,586	$44,730	$47,067	$64,130
Accrued Liabilities, Current	$12,726	$18,170	$21,012	$25,539
Employee-related Liabilities, Current	$43,430	$64,128	$70,409	$53,261
Convertible Debt, Current	—	$40,670	$0	$0
Operating Lease, Liability, Current	$17,060	$18,208	$19,472	$20,265
Contract with Customer, Liability, Current	$43,994	$11,831	$9,527	$8,430
Other Liabilities, Current	$28,462	$49,312	$75,237	$81,380
Liabilities, Current	$195,258	$247,049	$242,724	$253,005
Common Stock, Value, Issued	$66	$66	$68	$70
Additional Paid in Capital, Common Stock	$1,263,997	$1,312,804	$1,402,044	$1,418,011
Accumulated Other Comprehensive Income (Loss), Net of Tax	$1,369	$-1,947	$5,593	$6,403
Retained Earnings (Accumulated Deficit)	$-951,800	$-1,047,825	$-1,252,535	$-1,294,096
Stockholders' Equity Attributable to Parent	$313,632	$263,098	$155,170	$130,388
Common Stock, Shares Authorized	200,000,000	200,000,000	200,000,000	200,000,000
Common Stock, Shares, Issued	65,552,000	66,264,000	68,291,000	69,540,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-222,611	$-96,025	$-204,710	$-63,315
Net Cash Provided by (Used in) Operating Activities	$-31,810	$24,225	$-9,721	$-5,523
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$-212	$1,256	$1,612	$4,104
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-113,649	$10,366	$21,400	$-1,294
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$58,868	$69,234	$90,634	$216,385
Depreciation, Depletion and Amortization	$15,715	$16,607	$17,666	$17,962
Payments to Acquire Short-term Investments	$510,859	$264,311	$85,660	$319,676
Amortization of Debt Issuance Costs	$2,204	$2,089	$1,860	$2,274
Proceeds from Maturities, Prepayments and Calls of Short-term Investments	$546,218	$306,464	$257,072	$180,098
Accounts Receivable, Credit Loss Expense (Reversal)	$5,540	$9,979	$9,478	$11,259
Payments to Acquire Property, Plant, and Equipment	$26,804	$19,231	$19,948	$21,095
Payments to Acquire in Process Research and Development	$69,496	$0	$78,588	$35,124
Investment Income, Net, Amortization of Discount and Premium	$-3,587	$2,321	$3,828	$3,869
Income (Loss) from Equity Method Investments	—	$-2,053	$-14,194	$-16,783
Net Cash Provided by (Used in) Investing Activities	$-85,740	$-23,482	$72,876	$-277,224
Share-based Payment Arrangement, Noncash Expense	$88,076	$101,383	$92,381	$72,651
Gain (Loss) on Extinguishment of Debt	—	$-1,268	$0	$0
Research and Development Asset Acquired Other than Through Business Combination, Written-off	$78,750	$0	$75,217	$0
Other Operating Activities, Cash Flow Statement	$515	$-1,027	$4,363	$4,944
Proceeds from Convertible Debt	—	$306,850	$0	$291,157
Repayments of Convertible Debt	—	$246,123	$0	$0
Repayments of Notes Payable	—	—	$40,760	$0
Payments for Repurchase of Common Stock	—	$30,000	$0	$0
Proceeds from (Payments for) Other Financing Activities	$-71	$183	$0	$0
Net Cash Provided by (Used in) Financing Activities	$4,113	$8,367	$-43,367	$277,349
Interest Paid, Excluding Capitalized Interest, Operating Activities	$7,565	$3,076	$5,049	$5,049
Income Taxes Paid	$1,923	$3,098	$5,056	$5,056
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$0	$4,370	$26,169	$36,393
Capital Expenditures Incurred but Not yet Paid	$2,946	$511	$3,699	$4,477
Increase (Decrease) in Accounts Receivable	$-4,277	$20,795	$56,812	$46,378
Increase (Decrease) in Inventories	$46,053	$-5,810	$-24,816	$-4,194
Increase (Decrease) in Prepaid Expense and Other Assets	$9,139	$5,565	$9,088	$25,242
Increase (Decrease) in Other Noncurrent Assets	$3,187	$-893	$6,888	$21,546
Increase (Decrease) in Accounts Payable	$-4,864	$-2,392	$2,227	$19,988
Increase (Decrease) in Accrued Liabilities	$2,537	$5,550	$-664	$-664
Increase (Decrease) in Employee Related Liabilities	$5,167	$20,859	$5,995	$1,572
Increase (Decrease) in Contract with Customer, Liability	$21,525	$-34,736	$-4,788	$-5,860
IncreaseDecreaseInOperatingLeaseLiability	$4,302	$17,597	$19,225	$14,917
Increase (Decrease) in Other Noncurrent Liabilities	$7,750	$998	$2,938	$-5,193
Debt Issuance Costs, Net	—	$9,400	$9,400	$8,843
Debt Instrument, Repurchased Face Amount	—	$246,740	$246,740	$246,740

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("TNDM","financials")

Full statements spill as a table. For one cell: =jivedata("TNDM","Revenue") or =jivedata("TNDM","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.